1. Home
  2. HSDT

as 07-26-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Founded: N/A Country:
United States
United States
Employees: N/A City: NEWTOWN
Market Cap: 3.1M IPO Year: N/A
Target Price: $24.00 AVG Volume (30 days): 91.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -12.53 EPS Growth: N/A
52 Week Low/High: $0.73 - $13.43 Next Earning Date: 08-08-2024
Revenue: $668,000 Revenue Growth: -5.65%
Revenue Growth (this year): 11.34% Revenue Growth (next year): 85.76%

HSDT Daily Stock ML Predictions

Share on Social Networks: